SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
282Cimzia gets thumbs down in EU: Message 24127764 Meanwhile, Roche will almost ctuck-12/12/2007
281 <b>Waiting to inhale</b> sanfrancisco.bizjournals.com Howard Robiidos-12/3/2007
280Pfizer Cedes Control of Diabetes Drug By VAL BRICKATES KENNEDY November 14, 200Doc Bones-11/14/2007
279NKTR gets Exubera back and $135 million severance package from Pfizer. >>tuck-11/13/2007
278Give the chairman an A+ for candor....... By Ransdell Pierson NEW YORK, Oct 23Arthur Radley-10/23/2007
277See affy:-) eomdr.praveen-10/23/2007
276Mircera blocked: Message 23991285 This is not good news for NKTR, but the stoctuck-10/23/2007
275Derek Lowe and readers are "Surveying the Exubera Crater" pipeline.cotuck-10/22/2007
274online.wsj.com Very revealing article....and details of manufacturing route thiArthur Radley-10/20/2007
273In evaluating Nektar after Pfizer's bailing out of Eubera, we have to foucs tuck-10/20/2007
272I'm calling a low here of 4:20. -g-Archie Meeties-10/19/2007
271<b> Oh! The Humanity!... The Curse of Giles has finally struck. Crash andIan@SI-10/19/2007
270October 18, 2007, 7:49 am <b>Pfizer Gives Last Rites to Exubera</b> Ian@SI-10/19/2007
269Insulin Flop Costs Pfizer $2.8 Billion By AVERY JOHNSON October 19, 2007 Pfizezax-10/19/2007
268Looks like NKTR really doesn't want to ever work with PFE again... 2:44PM NIan@SI-10/18/2007
267From another PFE PR on a different thread, B NEWS? perhaps is this extract from Ian@SI-10/18/2007
266Here's the pr when pfizer bought the full rights from Sanofi..... Pfizer torkrw-10/18/2007
265Pfizer returns Exubera; no NKTR PR about this yet. >>Pfizer 3Q Profit Faltuck-10/18/2007
264As I predicted in July.........just can't figure out why PFE keep up the effArthur Radley-10/18/2007
263<<This one rank history of as to in pharmaceutical miscalculations the hasrkrw-10/18/2007
262PFE dumps Exubera, takes $2.8B writeoff: biz.yahoo.com <i>“…we made an iDewDiligence_on_SI-10/18/2007
261where is everyone ??? how come the stock is down today ???blind-geezer-9/27/2007
260Looks like it works well long term for all 2 pts. ;-) <b>New Data SupportIan@SI-9/18/2007
259>>Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118tuck-9/10/2007
258As the re-launch of Exubera staggers on, further commentary on its lack of succetuck-8/15/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News